SE368397

SE368397

1323383 A 13-ethyl-#4,9 steroid ROUSSELUCLAF 19 April 1971 [3 March 1970] 22970/71 Addition to 1127749 Heading C2U The invention comprises 13#-ethyl-17α- methyl - 18,19 - dinorpregna - 4,9 - diene - 3,20- dione and its preparation by oxidation of the corresponding 20α- or 20#-hydroxy compound or a m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WARNANT J,FR, JOLLY J,FR
Format: Patent
Sprache:eng
Schlagworte:
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
STEROIDS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1323383 A 13-ethyl-#4,9 steroid ROUSSELUCLAF 19 April 1971 [3 March 1970] 22970/71 Addition to 1127749 Heading C2U The invention comprises 13#-ethyl-17α- methyl - 18,19 - dinorpregna - 4,9 - diene - 3,20- dione and its preparation by oxidation of the corresponding 20α- or 20#-hydroxy compound or a mixture of these two isomers. The inventive compound is stated to possess antigonadotrophic, antiestrogenic, antiandrogenic and progestomimetic activities, and may be made up with carriers into pharmaceutical compositions for oral, parenteral, topical and rectal administration.